Stephan Maus - Department of Nuclear Medicine, Saarland University

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 89 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PSMA Radioligand Therapy in Advanced Age: Insights from an 85y+ Mcrpc Patient Cohort

Moritz B Bastian, Benedikt Wörl,Arne Blickle, Caroline Burgard, Tilman Speicher, Joel Wessendorf,Mark Bartholomä, Andrea Schaefer-Schuler,Stephan Maus,Samer Ezziddin,Florian Rosar

Clinical nuclear medicine (2025)

引用0浏览0WOS引用

Novel 64Cu-Labeled Trimeric PSMA Ligand Unequivocally Identifies Local Recurrence of Prostate Cancer Ambiguously Imaged by 18F-Dcfpyl PSMA PET/CT

Mark Bartholomä,Florian Rosar, Caroline Burgard,Stephan Maus, Moritz-Valentin Schreck,Samer Ezziddin

Clinical nuclear medicine (2025)

引用0浏览0WOS引用

Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in Mcrpc Patients with Preexisting Impaired Renal Function

Moritz B. Bastian, Maike Sieben,Caroline Burgard,Arne Blickle, Tilman Speicher,Mark Bartholomae,Stephan Maus,Sven Petto,Andrea Schaefer-Schuler,Samer Ezziddin,Florian Rosar

CLINICAL NUCLEAR MEDICINEno. 2 (2025): 165-171

引用0浏览0WOS引用

Radiochemistry of Cyclen-Derived Chelators Comprising Five-Membered Azaheterocyclic Arms with 212pb2+, 213bi3+, and 225Ac3

Ina Hierlmeier,Parmissa Randhawa,Brooke L McNeil, Elisa Oliveri,Stephan Maus,Valery Radchenko,Florian Rosar,Samer Ezziddin, Mark D Bartholomä

Nuclear medicine and biology (2025): 109034-109034

引用0浏览0WOS引用

Expanding the Scope of PSMA-RLT: Evaluating Treatment in Challenging Mcrpc Patients with Poor Performance Status (ECOG 3)

Moritz B Bastian, Benedikt Wörl,Arne Blickle, Caroline Burgard, Tilman Speicher,Mark Bartholomä, Andrea Schaefer-Schuler,Stephan Maus,Samer Ezziddin,Florian Rosar

European journal of nuclear medicine and molecular imaging (2025)

引用0浏览0WOS引用

First Successful In-Human Application of 225Ac-Dota-lm3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3)

Tilman Speicher,Caroline Burgard, Moritz Bastian,Florian Rosar,Mark Bartholomä,Stephan Maus,Samer Ezziddin

Clinical nuclear medicine（2025）

引用0浏览0WOS引用

Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival

Connor Hein,Caroline Burgard,Arne Blickle,Moritz B. Bastian,Stephan Maus,Andrea Schaefer-Schuler,Manuela A. Hoffmann,Mathias Schreckenberger,Samer Ezziddin,Florian Rosar

Cancersno. 15 (2024): 2670-2670

引用0浏览0WOS引用

Safety of PSMA Radioligand Therapy in Mcrpc Patients with Preexisting Moderate to Severe Thrombocytopenia

Moritz B. Bastian, Maike Sieben,Arne Blickle,Caroline Burgard, Tilman Speicher,Mark Bartholomä,Andrea Schaefer-Schuler,Stephan Maus,Samer Ezziddin,Florian Rosar

European Journal of Nuclear Medicine and Molecular Imagingpp.1-7, (2024)

引用0浏览0WOS引用

[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

Florian Rosar,Caroline Burgard, Elena Larsen,Fadi Khreish,Robert J. Marlowe,Andrea Schaefer-Schuler,Stephan Maus,Sven Petto,Mark Bartholomä,Samer Ezziddin

Cancer Imagingno. 1 (2024): 1-10

引用0浏览0WOS引用

225Ac-Psma-617 Augmentation in High-Risk Mcrpc Undergoing 177Lu-Psma-617 Radioligand Therapy

Florian Rosar,Caroline Burgard, Luna Vanessa Rohloff,Arne Blickle,Mark Bartholomae,Stephan Maus,Sven Petto,Andrea Schaefer-Schuler,Samer Ezziddin

CLINICAL NUCLEAR MEDICINE（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn